Shattuck Share Price

Shattuck Share Price

NASDAQ: STTK | Small Cap | Healthcare
$4.46
-$0.10 (-2.2%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Shattuck Stock Performance

Open
$4.56
Prev. Close
$4.55
Circuit Range
N/A
Day Range
$4.42 - $4.66
Year Range
$1.89 - $8.30
Volume
49,658
Average Traded
$4.50

Shattuck Share Price Today

As of 21 November 2026, Shattuck Labs, Inc.'s share price is $4.46. The stock opened at $4.56, compared to its previous close of $4.55. During today's trading session, Shattuck Labs, Inc.'s share price traded between $4.42 and $4.66, with an average price of $4.54. Over the past 52 weeks, the stock has recorded a high of $8.30 and a low of $1.89. In terms of performance, Shattuck Labs, Inc.'s share price has declined by 25.00% over the last six months and is up 113.67% on a year-on-year basis.

Shattuck Share Price Chart

Line chart of the Shattuck price trend over the selected period. The price fell overall, ranging from 4.42 to 4.66, ending at 4.46.
$4.42$4.66
L
Show Current Price
H

Shattuck Stock Fundamentals & Key Indicators

Market Cap
$310.00M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.66
Revenue (TTM)
$1.00B
Return On Equity (TTM)
-34.97%
Profit Margin
-4881.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-100.16%

Shattuck Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.59-$14.77-$15.15-$25.20
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-17.32%-2.57%-66.34%

Shattuck Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.65$1.66$5.72$1.00
Net Profit-$101.95-$87.30-$75.41-$48.81
Net Profit Margin-15684.62%-5259.04%-1318.36%-4881.00%
Income ChangeN/A14.37%13.62%35.27%

Shattuck Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets8.5511.8316.3420.74
Current Assets82.4879.22143.22184.58
Total Assets91.0391.05159.56205.32
Non Current Liabilities1.582.513.414.2
Current Liabilities7.058.9211.4524.97
Total Liabilities8.6411.4214.8629.17
Shareholders' Equity82.3979.63144.71176.16

Shattuck Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-39.88-60.52-81.23-94.5
Investing-7.89-8.51110.8649.44
Financing44.570.7948.620.17

About Shattuck

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Shattuck Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.57
$4.49
-19.32%
Oct 2026
$6.74
$5.57
-19.41%
Sep 2026
$6.97
$6.91
-9.74%
Aug 2026
$7.06
$7.65
+8.28%
Jul 2026
$7.04
$7.07
+1.95%
Jun 2026
$5.90
$6.93
+16.67%
May 2026
$7.10
$5.94
-16.69%
Apr 2026
$6.58
$7.13
+10.80%
Mar 2026
$3.85
$6.43
+63.95%
Feb 2026
$3.77
$3.92
+1.16%
Jan 2026
$3.66
$3.88
+6.59%
Dec 2025
$2.34
$3.64
+74.58%

Shattuck Share Price FAQs